Stock Events

Stock Events

Solana 

€2.06
52
+€0.39+23.35% Friday 10:49

Statistics

Day High
2.14
Day Low
1.84
52W High
2.14
52W Low
0.82
Volume
15
Avg. Volume
-
Mkt Cap
124.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-110.3
-73.54
-36.77
-0.01
Expected EPS
-0.008608000000000001
Actual EPS
N/A

Financials

-681.46%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
5.13MRevenue
-34.97MNet Income

Analyst Ratings

2.85Average Price Target
The highest estimate is 3.04.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 26H1.F. It's not an investment recommendation.
Microsoft
7
MSFT
Tesla
7
TSLA
Apple
6
AAPL
Realty Income
6
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
LivaNova
LIVN
Mkt Cap4.43B
LivaNova operates in the neuromodulation space, providing therapies for neurological disorders, which puts them in direct competition with Helius Medical Technologies.
Novartis
NVS
Mkt Cap292.35B
Novartis is a large pharmaceutical company with a broad portfolio that includes treatments for neurological conditions, competing on a larger scale with Helius's niche market.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie has a strong presence in neuroscience, including R&D in neuromodulation, making it a competitor by offering alternative treatments for similar conditions.
Medtronic
MDT
Mkt Cap116.77B
Medtronic offers a wide range of neuromodulation devices, directly competing with Helius in providing medical technologies for neurological disorders.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb, with its extensive portfolio in neuroscience, competes in developing treatments for conditions that Helius also aims to address with its technology.

About

Solana Co is a publicly listed digital asset treasury established in partnership with Pantera and Summer Capital. The company is dedicated to acquiring Solana (SOL) and aims to maximize SOL per share by strategically leveraging capital market opportunities and on-chain activities.
Show more...
CEO
Dane Carl Andreeff
Employees
21
Country
Canada
ISIN
US42328V8761
WKN
000A41AV3

Listings

STU
DE
26H1.STU
MU
DE
26H1.MU
F
DE
26H1.F
XNAS
US
HSDT

0 Comments

Share your thoughts

FAQ

What is Solana stock price today?▼
The current price of 26H1.F is €2.06 EUR — it has increased by +23.35% in the past 24 hours. Watch Solana stock price performance more closely on the chart.
What is Solana stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Solana stocks are traded under the ticker 26H1.F.
What is Solana market cap?▼
Today Solana has the market capitalization of 124.54M
When is the next Solana earnings date?▼
Solana is going to release the next earnings report on November 05, 2026.
What were Solana earnings last quarter?▼
26H1.F earnings for the last quarter are -0.33 EUR per share, whereas the estimation was -0.02 EUR resulting in a -1,800% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Solana revenue for the last year?▼
Solana revenue for the last year amounts to 5.13M EUR.
What is Solana net income for the last year?▼
26H1.F net income for the last year is -34.97M EUR.
How many employees does Solana have?▼
As of September 07, 2026, the company has 21 employees.
In which sector is Solana located?▼
Solana operates in the Health & Wellness sector.
When did Solana complete a stock split?▼
The last stock split for Solana was on July 01, 2025 with a ratio of 1:50.
Where is Solana headquartered?▼
Solana is headquartered in PHILADELPHIA, Canada.